These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2447403)

  • 41. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit.
    Weber MA; Oates HF; Stokes GS
    Clin Sci Mol Med Suppl; 1975 Jun; 2():89s-91s. PubMed ID: 28880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic responses to beta-adrenergic blockade with metoprolol and pindolol after coronary artery bypass surgery.
    Salmenperä M; Yrjölä H; Heikkilä J
    Chest; 1983 May; 83(5):739-43. PubMed ID: 6301764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.
    Bartsch W; Sponer G; Dietmann K
    Arzneimittelforschung; 1977; 27(12):2319-22. PubMed ID: 23798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs.
    Himori N; Izumi A; Ishimori T
    Am J Physiol; 1980 May; 238(5):F387-93. PubMed ID: 6103674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
    Akhras F; Jackson G
    Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
    Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose difference in beta-adrenergic blockers with intrinsic sympathomimetic action to block beta-adrenoceptors and induce sympathomimetic action.
    Takayanagi I; Ogishima M; Koike K; Hisayama T; Hayashida M; Fujii M
    Gen Pharmacol; 1989; 20(4):417-9. PubMed ID: 2568966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects.
    Mori T; Handa K; Terao Y; Tanaka H; Kiyonaga A; Shindo M; Matsunaga A; Sasaki J; Arakawa K
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):387-90. PubMed ID: 1381611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.
    Walden RJ; Bhattacharjee P; Tomlinson B; Cashin J; Graham BR; Prichard BN
    Br J Clin Pharmacol; 1982; 13(Suppl 2):359S-364S. PubMed ID: 6125188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of beta blockade with and without sympathomimetic activity (ISA) on sympathovagal balance and baroreflex sensitivity.
    Haberthür C; Schächinger H; Langewitz W; Ritz R
    Clin Physiol; 1999 Mar; 19(2):143-52. PubMed ID: 10200896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanism of beta-adrenergic receptor blockers with intrinsic sympathomimetic activity.
    Jasper JR; Michel MC; Insel PA
    FASEB J; 1988 Oct; 2(13):2891-4. PubMed ID: 2901994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
    J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-blockade with intrinsic sympathetic activity modifies favorably exercise-induced changes in plasma lipoproteins.
    Van Nguyen P; Cleroux J; Peterson M; Leenen FH
    J Appl Physiol (1985); 1990 Aug; 69(2):485-9. PubMed ID: 1977731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.
    Stokes GS; Graham RM; Weber MA
    Drugs; 1976; 11 SUPPL 1():150-6. PubMed ID: 6247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
    Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
    Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.